Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > Research > Cancer

Cancer

Cancer is the name given to a collection of related diseases. In all types of cancer the body’s cells begin to grow uncontrollably. The role of cancer research is to find ways to halt this growth.

Tackling cancer from many angles

Our work looks to improve the diagnosis and treatment of cancer. In particular, to alter the blood supply and to stop cells from spreading to new parts of the body.

As a result of many years of research some cancers in recent years have effective treatments. However, the most devastating are mostly untreatable. A feature of these cancers is their link to our diet and metabolism – another area of Centenary’s research.

We have many dedicated projects that cover specific types of cancer. Our researchers are currently looking at prostate, liver, breast and lung cancers, plus melanoma and leukaemia.

Our research Programs and Laboratories investigating cancer

  • ACRF Centenary Cancer Research Centre

    After centuries of cancer devastating almost half the population, the last decades of cancer research have brought unprecedented insights into the causation and treatment of this disease.
  • Gene and Stem Cell Therapy Program

    Our Gene and Stem Cell Therapy program focuses it’s research on cancer, heart disease and genetic diseases.
  • Epigenetics and RNA Biology Program

    We focus on discovering and understanding the roles of novel mechanisms that control gene expression in normal physiology and cancer.
  • Epigenetics of Melanoma Program

    The Epigenetics of Melanoma Program seeks to understand how deregulation of epigenetic modifiers can potentially govern all hallmarks of cancer. Using cutting edge techniques such as CRISPR, high throughput drug screening and mouse models, we seek to identify new targets for potential treatments.
    Dr Jess Tiffen
  • Liver Injury and Cancer Program

    Our work is devoted to understanding pathways at the cellular and molecular levels that drive liver injury and cancer. These pathways may then be identified as targets to modulate these processes or be used for diagnosis and staging of liver disease and cancer.
    Prof Geoff McCaughan
  • Melanoma Oncology and Immunology Program

    The current focus of melanoma research at the Centenary Institute is to better understand the resistance of certain melanoma to new treatments. We are particularly interested in the role of epigenetic regulation in resistance and the role of new drugs targeting these mechanisms in treatment of melanoma.
  • Cancer and Gene Regulation Laboratory

    Gene regulation is frequently dysregulated in cancer. During cancer initiation, transcription factors can exhibit somatic mutations including point mutations in regulatory domains or undergo copy number variations due to genetic deletion.
  • Computational BioMedicine Laboratory

    In the Computational BioMedicine lab, we develop integrative workflows combining various computational disciplines with experimentation to address questions around non-coding RNAs, post-transcriptional gene regulation and cancer biology.
  • Directed Evolution Laboratory

    In the Directed Evolution laboratory, we harness the power of Darwinian selection to evolve proteins with new therapeutic activities. Starting with unique proteins from all domains of life we aim to produce first-in-class or vastly improved drugs for intractable diseases.

Achievements

  • New precision medicine laboratory to help fight cancer

    The Centenary Institute has announced it will establish a new precision medicine laboratory, enabling world-leading research into the use of theranostics to treat cancer, thanks to a grant from the Australian Cancer Research Foundation (ACRF).
    Read more
  • Metastatic cancer research boosted

    Dr Dannel Yeo from the Centenary Institute and Clinical Associate Professor Kate Mahon from Chris O’Brien Lifehouse, have been awarded an inaugural Sydney Cancer Partners Translational Fellowship.
    Read more
  • DPP9 enzyme role in cancer revealed

    A new study from German and Centenary Institute researchers has provided new understanding of an enzyme called dipeptidyl peptidase 9 (DPP9) and its role in cancer development.
    Read more

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram